Past GEST Meeting → GEST 2018

Hepatocellular Carcinoma (HCC Part II) (GEST18-106)


Description
Faculty: Dr. Jin Wook Chung - Seoul National University Hospital Dr. Shiro Miyayama – Fukuiken Saiseikai Hospital Dr. Marcelo Guimaraes - Medical University of South Carolina Dr. Toshihiro Tanaka - Nara Medical University Dr. Edward Kim - Icahn School of Medicine at Mount Sinai Dr. Beau Toskich – Mayo Clinic Florida Dr. Michael Soulen - Abramson Cancer Center / University of Pennsylvania Dr. Riad Salem – Northwestern University

CME Credits: None MOC Credits: None Category: IO: Hepatocellular Carcinoma (HCC)

Content
  • Dr Chung - Tumor Blood Supply & Angioarchitecture of HCC
  • Dr. Miyayama - Ultraselective TACE Guided by Advanced Imaging Technology
  • Dr. Guimaraes - Combination of TACE and Ablation Therapy
  • Dr. Tanaka - Management of Arterio-Venous and Arterio-Portal Shunts
  • Dr. Kim - Portal Vein Invasion: How to Manage
  • Dr. Toskich - Radiation Segmentectomy: Rational and Outcome
  • Dr. Kim - How Do I Decide: Transarterial Therapies
  • Dr. Soulen - Embolotherapy of HCC: Red, Hot, or Not?
  • Dr. Salem - Crossing the 1000-Patient Milestone of Y90 for HCC
Completion rules
  • All units must be completed